In a filing, Monopar Therapeutics Inc revealed its Chief Financial Officer Radhakrishnan Karthik acquired Company’s shares for reported $25188.0 on Oct 28 ’24. In the deal valued at $16.25 per share,1,550 shares were bought. As a result of this transaction, Radhakrishnan Karthik now holds 1,550 shares worth roughly $26288.0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Cittadine Andrew bought 20,508 shares, generating $15,254 in total proceeds. Upon buying the shares at $0.74, the Chief Operating Officer now owns 186,132 shares.
Before that, Cittadine Andrew bought 12,000 shares. Monopar Therapeutics Inc shares valued at $10,320 were divested by the Chief Operating Officer at a price of $0.86 per share. As a result of the transaction, Cittadine Andrew now holds 165,624 shares, worth roughly $2.81 million.
Rodman & Renshaw initiated its Monopar Therapeutics Inc [MNPR] rating to a Buy in a research note published on October 11, 2024; the price target was $50. A number of analysts have revised their coverage, including ROTH Capital’s analysts, who began to cover the stock in late January with a ‘”a Buy”‘ rating.
Price Performance Review of MNPR
On Monday, Monopar Therapeutics Inc [NASDAQ:MNPR] saw its stock jump 15.93% to $16.96. Over the last five days, the stock has lost -4.88%. Monopar Therapeutics Inc shares have risen nearly 897.06% since the year began. Nevertheless, the stocks have risen 558.64% over the past one year. While a 52-week high of $38.50 was reached on 10/24/24, a 52-week low of $1.37 was recorded on 02/07/24. SMA at 50 days reached $6.46, while 200 days put it at $4.11.
Levels Of Support And Resistance For MNPR Stock
The 24-hour chart illustrates a support level at 14.53, which if violated will result in even more drops to 12.11. On the upside, there is a resistance level at 18.79. A further resistance level may holdings at 20.63. The Relative Strength Index (RSI) on the 14-day chart is 60.03, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.81, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 63.35%. Stochastics %K at 32.02% indicates the stock is a holding.
How much short interest is there in Monopar Therapeutics Inc?
A steep rise in short interest was recorded in Monopar Therapeutics Inc stocks on 2024-10-15, dropping by -0.6 million shares to a total of 49852.0 shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 0.65 million shares. There was a decline of -1208.86%, which implies that there is a negative sentiment for the stock.
